tiprankstipranks
Trending News
More News >
Advertisement

IDVZ - ETF AI Analysis

Compare

Top Page

IDVZ

Opal International Dividend Income ETF (IDVZ)

Rating:59Neutral
Price Target:
IDVZ, the Opal International Dividend Income ETF, has a solid overall rating that reflects a mix of strong, income-focused global companies alongside a few more uncertain names. High-quality holdings like TSMC, GSK, and Reckitt Benckiser support the fund’s score with strong financial performance, positive earnings outlooks, and attractive dividends, while companies such as British American Tobacco and Royal KPN introduce some risk due to revenue pressures, leverage, and mixed technical trends. The main risk factor is that several holdings show weak or cautious price momentum and specific business challenges, which can create volatility even though the underlying businesses are generally stable and income-oriented.
Positive Factors
Solid Recent Performance
The ETF has shown steady gains over the past month, three months, and year-to-date, indicating positive recent momentum.
Strong Top Holdings Mix
Several of the largest positions, including major financial, healthcare, and technology names, have delivered strong gains that support the fund’s overall returns.
Broad Sector Diversification
Holdings spread across defensive, financial, communication, healthcare, technology, and energy sectors help reduce the impact if any one industry struggles.
Negative Factors
High Expense Ratio
The fund’s relatively high fee means more of the investment return goes to costs instead of staying in investors’ pockets.
Heavy U.S. Concentration
With the vast majority of assets in U.S. companies, investors get limited geographic diversification and remain highly tied to the U.S. market.
Mixed Performance Among Top Holdings
A few of the largest positions have shown weak or negative performance, which can drag on the ETF if those stocks continue to lag.

IDVZ vs. SPDR S&P 500 ETF (SPY)

IDVZ Summary

The Opal International Dividend Income ETF (IDVZ) is a global fund that focuses on companies paying high dividends, without tracking a specific index. It mainly holds international stocks across many sectors, including consumer, financial, and healthcare businesses. Well-known holdings include chipmaker TSMC and drugmaker Novo Nordisk. Someone might invest in IDVZ to seek regular income from dividends while getting diversification across countries and industries. A key risk is that dividend-paying stocks and international markets can go up and down in value, so your investment is not guaranteed and may lose money.
How much will it cost me?The Opal International Dividend Income ETF (IDVZ) has an expense ratio of 0.75%, which means you’ll pay $7.50 per year for every $1,000 invested. This is higher than average because the fund is actively managed to focus on high dividend yield opportunities across global markets, requiring more research and management effort.
What would affect this ETF?The Opal International Dividend Income ETF (IDVZ) could benefit from global economic growth and increased demand for dividend-paying stocks, especially in sectors like Consumer Defensive and Financials, which make up a significant portion of its holdings. However, it may face challenges from rising interest rates, which can make dividend-focused investments less attractive, and potential regulatory changes or geopolitical tensions in its international markets. Its exposure to diverse sectors and regions helps mitigate risks but does not eliminate them entirely.

IDVZ Top 10 Holdings

IDVZ leans heavily on steady, dividend-rich giants overseas, with Europe doing much of the heavy lifting. Financials like BNP Paribas and UBS have been rising and now act as key engines for the fund, while TSMC and Novo Nordisk add a growth twist from the tech and healthcare side, also trending higher. On the flip side, telecom names such as Royal KPN and, to a lesser extent, Orange are losing steam and dragging on returns. Overall, it’s a global ex-U.S. income play, tilted toward European defensives and banks.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Orange SA4.62%$6.71M$52.77B75.47%
63
Neutral
GlaxoSmithKline4.47%$6.50M$123.00B64.64%
77
Outperform
BNP Paribas3.78%$5.49M$122.41B52.04%
72
Outperform
Reckitt Benckiser Group3.65%$5.31M$56.11B25.56%
78
Outperform
Royal KPN3.48%$5.05M$20.66B48.90%
68
Neutral
Enel SpA Unsponsored ADR3.42%$4.96M$110.95B54.33%
71
Outperform
Petroleo Brasileiro SA- Petrobras3.34%$4.85M$95.23B5.63%
69
Neutral
TSMC3.22%$4.68M$1.57T80.10%
81
Outperform
British American Tobacco3.09%$4.49M$126.61B58.21%
59
Neutral
Rio Tinto2.83%$4.11M$167.64B49.85%
80
Outperform

IDVZ Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
32.82
Positive
100DMA
31.68
Positive
200DMA
30.30
Positive
Market Momentum
MACD
0.69
Positive
RSI
73.85
Negative
STOCH
70.61
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For IDVZ, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 34.39, equal to the 50-day MA of 32.82, and equal to the 200-day MA of 30.30, indicating a bullish trend. The MACD of 0.69 indicates Positive momentum. The RSI at 73.85 is Negative, neither overbought nor oversold. The STOCH value of 70.61 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for IDVZ.

IDVZ Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$144.93M0.75%
$621.82M0.50%
$224.18M0.59%
$164.53M0.49%
$145.43M0.35%
$15.51M0.39%
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IDVZ
Opal International Dividend Income ETF
35.06
9.09
35.00%
FDV
Federated Hermes U.S. Strategic Dividend ETF
TBG
TBG Dividend Focus ETF
ELCV
Eventide High Dividend ETF
HIDV
AB US High Dividend ETF
VDI
Virtus International Dividend ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement